Clinical Scenarios: When to Use or DePrioritize Metformin Scenario 1: Newly Diagnosed, Low Cardiovascular Risk A 48-year-old patient with newly diagnosed type 2 diabetes, an A1C of 7.3%, and no cardiovascular risk factors may still benefit from starting metformin
Saber mais sobre a BONO Ainda tens perguntas
Published online January 14, 2026
59 Djouadi F, Riveau B, Merlet-Benichou C, Bastin J
The focus here is research-use-only product evaluation: compound identity, COA review, analytical testing, lot traceability, supplier documentation, and careful separation of published literature from product claims
Drach J, Pereira-Leahy M, Sanchez-Williams G, Dunne C, Zhao S, Liu Y, Estey E, Andreeff M